Lurker Nancy Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$533,472.44
Insider Sells Quantity
4
Insider Sells Sum
$1.69M

Insider Activity of Lurker Nancy

According to the SEC Form 4 filings, Lurker Nancy, being in a position of

  1. director at Collegium Pharmaceutical, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 4500 shares for $161,861,
    over all time since 2026-05-13, has bought 0 shares, and sold 4500 shares for $161,861.

Biography of Lurker Nancy

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$312,8034100

Comparison of Insiders on Amount of Buys and Sells

2026-05-13SaleCollegium Pharmaceutical, Inc.
COLL
director
4,500
0.0143%
$35.97$161,861-17.92%
2025-12-04SaleEyePoint Pharmaceuticals, Inc.
EYPT
director
9,300
0.0122%
$15.11$140,477-20.51%
2025-11-28SaleEyePoint Pharmaceuticals, Inc.
EYPT
director
500
0.0007%
$14.95$7,475-10.32%
2025-11-26SaleEyePoint Pharmaceuticals, Inc.
EYPT
director
200
0.0003%
$14.95$2,990-9.94%
2024-08-16PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
director
3,173
0.0057%
$7.88$25,003+3.91%
2024-01-24SaleEyePoint Pharmaceuticals, Inc.
EYPT
Executive Vice Chair
29,956
0.0887%
$24.98$748,250-60.48%
2024-01-23SaleEyePoint Pharmaceuticals, Inc.
EYPT
Executive Vice Chair
5,044
0.0144%
$24.97$125,950-61.98%
2023-12-04SaleEyePoint Pharmaceuticals, Inc.
EYPT
Executive Vice Chair
20,000
0.0629%
$20.76$415,200-37.49%
2021-11-15SaleEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
20,000
0.098%
$20.15$402,960-31.12%
2020-03-10PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
196,000
0.1715%
$1.06$208,054-28.57%
2019-03-29PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
President & CEO
57,000
0.0588%
$1.76$100,491-11.73%
2017-06-14PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
President and CEO
113,400
0.3232%
$1.76$199,924-30%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.